Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 08, 2023

BUY
$0.96 - $2.92 $240,000 - $730,000
250,000 New
250,000 $315,000
Q2 2022

Aug 03, 2022

SELL
$5.97 - $9.97 $2.39 Million - $3.99 Million
-400,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.25 - $13.23 $2.9 Million - $5.29 Million
400,000 New
400,000 $5.03 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $84.6M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.